Yokose C - Search Results

1

Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis.

Yokose C, Challener G, Jiang B, Zhou B, McCormick N, Tanikella S, Panchot KMQ, Kohler MJ, Yinh J, Zhang Y, Bates DW, Januzzi JL, Sise M, Wexler D, Choi HK. Yokose C, et al. Semin Arthritis Rheum. 2024 Jun;66:152441. doi: 10.1016/j.semarthrit.2024.152441. Epub 2024 Apr 5. Semin Arthritis Rheum. 2024. PMID: 38657403

2

Unclosing Premature Mortality Gap Among Patients With Gout in the US General Population, Independent of Serum Urate and Atherosclerotic Cardiovascular Risk Factors.

McCormick N, Lin K, Yokose C, Lu N, Zhang Y, Choi HK. McCormick N, et al. Among authors: yokose c. Arthritis Care Res (Hoboken). 2024 May;76(5):691-702. doi: 10.1002/acr.25292. Epub 2024 Feb 14. Arthritis Care Res (Hoboken). 2024. PMID: 38191784

3

The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.

Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Lioté F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK. Yokose C, et al. Nat Rev Rheumatol. 2024 Apr;20(4):216-231. doi: 10.1038/s41584-024-01092-x. Epub 2024 Mar 12. Nat Rev Rheumatol. 2024. PMID: 38472344 Review.

4

Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin.

McCormick N, Yokose C, Lu N, Wexler DJ, Aviña-Zubieta JA, De Vera MA, McCoy RG, Choi HK. McCormick N, et al. Among authors: yokose c. JAMA Intern Med. 2024 Apr 15:e240376. doi: 10.1001/jamainternmed.2024.0376. Online ahead of print. JAMA Intern Med. 2024. PMID: 38619822

5

Serum Urate and Recurrent Gout.

McCormick N, Yokose C, Challener GJ, Joshi AD, Tanikella S, Choi HK. McCormick N, et al. Among authors: yokose c. JAMA. 2024 Feb 6;331(5):417-424. doi: 10.1001/jama.2023.26640. JAMA. 2024. PMID: 38319333

6

Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT.

Yokose C, Dalbeth N, Wei J, Nicolaou S, Simeone FJ, Baumgartner S, Fung M, Zhang Y, Choi HK. Yokose C, et al. Semin Arthritis Rheum. 2020 Feb;50(1):54-58. doi: 10.1016/j.semarthrit.2019.07.002. Epub 2019 Jul 11. Semin Arthritis Rheum. 2020. PMID: 31371194 Free PMC article.

7

Population Impact Attributable to Modifiable Risk Factors for Hyperuricemia.

Choi HK, McCormick N, Lu N, Rai SK, Yokose C, Zhang Y. Choi HK, et al. Among authors: yokose c. Arthritis Rheumatol. 2020 Jan;72(1):157-165. doi: 10.1002/art.41067. Epub 2019 Dec 3. Arthritis Rheumatol. 2020. PMID: 31486212 Free PMC article.

8

Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study.

Yokose C, Jorge A, D'Silva K, Serling-Boyd N, Matza M, Nasrallah M, Keller S, Oza A, Choi H, Bolster MB, Collier D. Yokose C, et al. Semin Arthritis Rheum. 2020 Dec;50(6):1382-1386. doi: 10.1016/j.semarthrit.2020.03.001. Epub 2020 Mar 16. Semin Arthritis Rheum. 2020. PMID: 32359694 Free PMC article.

9

Hypouricemia and Mortality Risk in the US General Population.

D'Silva KM, Yokose C, Lu N, McCormick N, Lee H, Zhang Y, Choi HK. D'Silva KM, et al. Among authors: yokose c. Arthritis Care Res (Hoboken). 2021 Aug;73(8):1171-1179. doi: 10.1002/acr.24476. Epub 2021 Jul 12. Arthritis Care Res (Hoboken). 2021. PMID: 33026684 Free PMC article.

10

The role of diet in hyperuricemia and gout.

Yokose C, McCormick N, Choi HK. Yokose C, et al. Curr Opin Rheumatol. 2021 Mar 1;33(2):135-144. doi: 10.1097/BOR.0000000000000779. Curr Opin Rheumatol. 2021. PMID: 33399399 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page